Clinical Trials Browser

Phase 2 × SCCHN × pembrolizumab × Clear all

NCT03771820 2021-03-17

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

Phase 2 Unknown

SCCHN